IRIDEX CORP (IRIX) Stock Price, Financials & Summary

Price chart

Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18

Key dataSep 18, 2026

Open$0.64

From 52W high−57.05%

Volume75138.00

Market cap$11.77M

P/E (TTM)—

P/S (TTM)0.2x

Div yield—

Key dataSep 18, 2026

Open

$0.64

From 52W high

−57.05%

Volume

75138.00

Market cap

$11.77M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−10.0x

P/E (TTM)

—

RSI (14)

33.0

MomentumView details →

1D Return

+2.81%

YTD Return

−43.77%

SummaryUpdated Jul 1, 2026

IRIDEX Corporation (NASDAQ:IRIX) is a specialized ophthalmic medical technology company founded in 1989 and headquartered in Mountain View, California. The company went public in 1996 and has established itself as a provider of therapeutic laser systems and related devices for treating sight-threatening eye diseases. IRIDEX focuses primarily on two major areas of ophthalmology: glaucoma and retinal disorders, serving eye care professionals worldwide through both direct sales and international distribution networks.

Ask drillr about IRIDEX CORP →

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−10.0x

EV/Sales

0.3x

P/S (TTM)

0.2x

P/B (TTM)

3.2x

ProfitabilityView details →

Gross Margin

36.23%

Net Margin

−6.88%

EBITDA Margin

−3.31%

ROE (TTM)

−97.47%

ROA (TTM)

−13.01%

Asset Turnover

1.86x

GrowthView details →

Revenue YoY

+3.68%

EPS YoY

+38.23%

FCF YoY

+70.01%

Revenue CAGR 3Y

−2.58%

EPS CAGR 3Y

+51.85%

EBITDA YoY

+52.72%

MomentumView details →

1D Return

+2.81%

YTD Return

−43.77%

1Y Return

−46.13%

RSI (14)

33.0

vs 50D SMA

−21.08%

vs 200D SMA

−41.29%

Capital & dividendView details →

Debt/Equity

1.10x

Current Ratio

1.82x

Quick Ratio

1.08x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$0.07

EPS Surprise

−600.00%

Beats (12Q)

6/12

Next Q EPS Est

−$0.04

Avg Surprise (4Q)

−114.88%

Rev Surprise

−7.51%

Financials snapshotView financials →

Revenue (TTM)

51.57M

Net Income (TTM)

−3.55M

Op. CF (TTM)

−1.73M

Next earningsNov 17, 2026 →

Latest newsMore news →

IRIDEX Corp received a notice from NASDAQ on 2026-08-27 stating it no longer meets the minimum bid price requirement under Rule 5550(a)(2), and has until 2027-02-23 to regain compliance.18d ago

Iridex Corporation reported its financial results for the second quarter ended July 4, 2026.33d ago

Similar companies

Sintx Technologies, Inc.SINT Biomerica, Inc.BMRA NeuroOne Medical Technologies CorporationNMTC Adagio Medical Holdings, Inc.ADGM Aethlon Medical, Inc.AEMD Pulsenmore Ltd. Ordinary SharesPLSM Find similar companies →

Latest newsMore news →

IRIDEX Corp received a notice from NASDAQ on 2026-08-27 stating it no longer meets the minimum bid price requirement under Rule 5550(a)(2), and has until 2027-02-23 to regain compliance.18d ago Iridex Corporation reported its financial results for the second quarter ended July 4, 2026.33d ago